Receipt of prescription opioid medication is associated with increased mortality in an Israeli population
ConclusionIncreased opioid use is independently associated with increased all-cause mortality among non-oncological patients. This result is most notable among young adults with little or no known comorbidities. These findings are consistent with results in other countries and seem more credible than previous Israeli reports. Healthcare regulators and providers should, therefore, act to curtail the increasing opioid prescriptions and devise and enhance controls in the healthcare system, which, until 2020, had very limited mechanisms in place. (Source: Israel Journal of Health Policy Research)
Source: Israel Journal of Health Policy Research - April 3, 2024 Category: International Medicine & Public Health Source Type: research

Risks for re-hospitalization of persons with severe mental illness living in rehabilitation care settings
ConclusionFindings revealed that among the three Health Behavior Model factors, theneed factor best predicted re-hospitalization. Theenabling factor, comprised of personal relationships and social/vocational activities facilitated by interventions and services representing many of psychiatric rehabilitation ’s key goals, had the weakest association with reduced rates of re-hospitalization. Possible explanations may be inaccurate assessments of consumers' personal relationships and social/vocational activities by the mental healthcare professionals, problematic provider-consumer communication on the c onsumers' involvemen...
Source: Israel Journal of Health Policy Research - April 3, 2024 Category: International Medicine & Public Health Source Type: research

HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening
CONCLUSIONS: There is a high prevalence of hr-HPV among WLHIV in both rural and urban settings in this study in Ghana. Concurrent HPV DNA testing with a visual inspection method (colposcopy/VIA) reduces loss to follow-up compared to performing HPV DNA testing as a standalone test and recalling hr-HPV positive women for follow up with a visual inspection method. Concurrent HPV DNA testing and a visual inspection method may also pick up precancerous cervical lesions that are hr-HPV negative and may be missed if HPV DNA testing is performed alone.PMID:38563112 | DOI:10.1177/10732748241244678 (Source: Cancer Control)
Source: Cancer Control - April 2, 2024 Category: Cancer & Oncology Authors: Kofi Effah Richard Anthony Ethel Tekpor Joseph E Amuah Comfort M Wormenor Georgina Tay Smith E Y Kraa Angela M Katso Christiana A Akonnor Seyram Kemawor Stephen Danyo Bernard H Atuguba Nana Owusu M Essel Patrick K Akakpo Source Type: research

Target product profiles: leprosy diagnostics
Bull World Health Organ. 2024 Apr 1;102(4):288-295. doi: 10.2471/BLT.23.290881. Epub 2024 Feb 22.ABSTRACTThe World Health Organization (WHO) aims to reduce new leprosy cases by 70% by 2030, necessitating advancements in leprosy diagnostics. Here we discuss the development of two WHO's target product profiles for such diagnostics. These profiles define criteria for product use, design, performance, configuration and distribution, with a focus on accessibility and affordability. The first target product profile outlines requirements for tests to confirm diagnosis of leprosy in individuals with clinical signs and symptoms, to...
Source: Bulletin of the World Health Organization - April 2, 2024 Category: International Medicine & Public Health Authors: Petra Kukkaro Sundeep Chaitanya Vedithi David J Blok Wim H van Brakel Annemieke Geluk Aparna Srikantam David Scollard Linda B Adams Mathias Duck Sunil Anand Andie Tucker Israel Cruz Vrr Pemmaraju Daniel Argaw Dagne Kingsley Asiedu Christopher Hanna Source Type: research

Target product profiles: leprosy diagnostics
Bull World Health Organ. 2024 Apr 1;102(4):288-295. doi: 10.2471/BLT.23.290881. Epub 2024 Feb 22.ABSTRACTThe World Health Organization (WHO) aims to reduce new leprosy cases by 70% by 2030, necessitating advancements in leprosy diagnostics. Here we discuss the development of two WHO's target product profiles for such diagnostics. These profiles define criteria for product use, design, performance, configuration and distribution, with a focus on accessibility and affordability. The first target product profile outlines requirements for tests to confirm diagnosis of leprosy in individuals with clinical signs and symptoms, to...
Source: Bulletin of the World Health Organization - April 2, 2024 Category: International Medicine & Public Health Authors: Petra Kukkaro Sundeep Chaitanya Vedithi David J Blok Wim H van Brakel Annemieke Geluk Aparna Srikantam David Scollard Linda B Adams Mathias Duck Sunil Anand Andie Tucker Israel Cruz Vrr Pemmaraju Daniel Argaw Dagne Kingsley Asiedu Christopher Hanna Source Type: research

Target product profiles: leprosy diagnostics
Bull World Health Organ. 2024 Apr 1;102(4):288-295. doi: 10.2471/BLT.23.290881. Epub 2024 Feb 22.ABSTRACTThe World Health Organization (WHO) aims to reduce new leprosy cases by 70% by 2030, necessitating advancements in leprosy diagnostics. Here we discuss the development of two WHO's target product profiles for such diagnostics. These profiles define criteria for product use, design, performance, configuration and distribution, with a focus on accessibility and affordability. The first target product profile outlines requirements for tests to confirm diagnosis of leprosy in individuals with clinical signs and symptoms, to...
Source: Bulletin of the World Health Organization - April 2, 2024 Category: International Medicine & Public Health Authors: Petra Kukkaro Sundeep Chaitanya Vedithi David J Blok Wim H van Brakel Annemieke Geluk Aparna Srikantam David Scollard Linda B Adams Mathias Duck Sunil Anand Andie Tucker Israel Cruz Vrr Pemmaraju Daniel Argaw Dagne Kingsley Asiedu Christopher Hanna Source Type: research

Target product profiles: leprosy diagnostics
Bull World Health Organ. 2024 Apr 1;102(4):288-295. doi: 10.2471/BLT.23.290881. Epub 2024 Feb 22.ABSTRACTThe World Health Organization (WHO) aims to reduce new leprosy cases by 70% by 2030, necessitating advancements in leprosy diagnostics. Here we discuss the development of two WHO's target product profiles for such diagnostics. These profiles define criteria for product use, design, performance, configuration and distribution, with a focus on accessibility and affordability. The first target product profile outlines requirements for tests to confirm diagnosis of leprosy in individuals with clinical signs and symptoms, to...
Source: Bulletin of the World Health Organization - April 2, 2024 Category: International Medicine & Public Health Authors: Petra Kukkaro Sundeep Chaitanya Vedithi David J Blok Wim H van Brakel Annemieke Geluk Aparna Srikantam David Scollard Linda B Adams Mathias Duck Sunil Anand Andie Tucker Israel Cruz Vrr Pemmaraju Daniel Argaw Dagne Kingsley Asiedu Christopher Hanna Source Type: research

Target product profiles: leprosy diagnostics
Bull World Health Organ. 2024 Apr 1;102(4):288-295. doi: 10.2471/BLT.23.290881. Epub 2024 Feb 22.ABSTRACTThe World Health Organization (WHO) aims to reduce new leprosy cases by 70% by 2030, necessitating advancements in leprosy diagnostics. Here we discuss the development of two WHO's target product profiles for such diagnostics. These profiles define criteria for product use, design, performance, configuration and distribution, with a focus on accessibility and affordability. The first target product profile outlines requirements for tests to confirm diagnosis of leprosy in individuals with clinical signs and symptoms, to...
Source: Bulletin of the World Health Organization - April 2, 2024 Category: International Medicine & Public Health Authors: Petra Kukkaro Sundeep Chaitanya Vedithi David J Blok Wim H van Brakel Annemieke Geluk Aparna Srikantam David Scollard Linda B Adams Mathias Duck Sunil Anand Andie Tucker Israel Cruz Vrr Pemmaraju Daniel Argaw Dagne Kingsley Asiedu Christopher Hanna Source Type: research

Target product profiles: leprosy diagnostics
Bull World Health Organ. 2024 Apr 1;102(4):288-295. doi: 10.2471/BLT.23.290881. Epub 2024 Feb 22.ABSTRACTThe World Health Organization (WHO) aims to reduce new leprosy cases by 70% by 2030, necessitating advancements in leprosy diagnostics. Here we discuss the development of two WHO's target product profiles for such diagnostics. These profiles define criteria for product use, design, performance, configuration and distribution, with a focus on accessibility and affordability. The first target product profile outlines requirements for tests to confirm diagnosis of leprosy in individuals with clinical signs and symptoms, to...
Source: Bulletin of the World Health Organization - April 2, 2024 Category: International Medicine & Public Health Authors: Petra Kukkaro Sundeep Chaitanya Vedithi David J Blok Wim H van Brakel Annemieke Geluk Aparna Srikantam David Scollard Linda B Adams Mathias Duck Sunil Anand Andie Tucker Israel Cruz Vrr Pemmaraju Daniel Argaw Dagne Kingsley Asiedu Christopher Hanna Source Type: research

Target product profiles: leprosy diagnostics
Bull World Health Organ. 2024 Apr 1;102(4):288-295. doi: 10.2471/BLT.23.290881. Epub 2024 Feb 22.ABSTRACTThe World Health Organization (WHO) aims to reduce new leprosy cases by 70% by 2030, necessitating advancements in leprosy diagnostics. Here we discuss the development of two WHO's target product profiles for such diagnostics. These profiles define criteria for product use, design, performance, configuration and distribution, with a focus on accessibility and affordability. The first target product profile outlines requirements for tests to confirm diagnosis of leprosy in individuals with clinical signs and symptoms, to...
Source: Bulletin of the World Health Organization - April 2, 2024 Category: International Medicine & Public Health Authors: Petra Kukkaro Sundeep Chaitanya Vedithi David J Blok Wim H van Brakel Annemieke Geluk Aparna Srikantam David Scollard Linda B Adams Mathias Duck Sunil Anand Andie Tucker Israel Cruz Vrr Pemmaraju Daniel Argaw Dagne Kingsley Asiedu Christopher Hanna Source Type: research

Target product profiles: leprosy diagnostics
Bull World Health Organ. 2024 Apr 1;102(4):288-295. doi: 10.2471/BLT.23.290881. Epub 2024 Feb 22.ABSTRACTThe World Health Organization (WHO) aims to reduce new leprosy cases by 70% by 2030, necessitating advancements in leprosy diagnostics. Here we discuss the development of two WHO's target product profiles for such diagnostics. These profiles define criteria for product use, design, performance, configuration and distribution, with a focus on accessibility and affordability. The first target product profile outlines requirements for tests to confirm diagnosis of leprosy in individuals with clinical signs and symptoms, to...
Source: Bulletin of the World Health Organization - April 2, 2024 Category: International Medicine & Public Health Authors: Petra Kukkaro Sundeep Chaitanya Vedithi David J Blok Wim H van Brakel Annemieke Geluk Aparna Srikantam David Scollard Linda B Adams Mathias Duck Sunil Anand Andie Tucker Israel Cruz Vrr Pemmaraju Daniel Argaw Dagne Kingsley Asiedu Christopher Hanna Source Type: research